Substituted quinazolinyl compounds useful as T cell activators
US-12492172-B2 · Dec 9, 2025 · US
This page is not indexed by search engines while we improve data quality.
Rahaman Hasibur patents
Rahaman Hasibur is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rahaman Hasibur |
| Total patents | 30 |
| First publication | Sep 8, 2016 |
| Latest publication | Dec 9, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted pyridopyrimidinonyl compounds useful as t cell activators
US-2024400563-A1 · Dec 5, 2024 · US
Kras g12d inhibitors
US-2024317769-A1 · Sep 26, 2024 · US
Kras inhibitors
US-2024217982-A1 · Jul 4, 2024 · US
Combination of a t cell therapy and a dgk inhibitor
US-2024108654-A1 · Apr 4, 2024 · US
Substituted naphthyridinone compounds useful as T cell activators
US-11713316-B2 · Aug 1, 2023 · US
Substituted pyridopyrimidinonyl compounds useful as t cell activators
US-2023151007-A1 · May 18, 2023 · US
Substituted quinazolinyl compounds useful as t cell activators
US-2023094758-A1 · Mar 30, 2023 · US
Substituted pyridopyrimidinonyl compounds useful as T cell activators
US-11584747-B2 · Feb 21, 2023 · US
Substituted naphthyridinone compounds useful as t cell activators
US-2022324859-A1 · Oct 13, 2022 · US
Recent patents
Latest publications not already listed above.
TGF-beta inhibitors
US-11352360-B2 · Jun 7, 2022 · US
TGF beta receptor antagonists
US-10961239-B2 · Mar 30, 2021 · US
Substituted naphthyridinone compounds useful as T cell activators
US-10954238-B1 · Mar 23, 2021 · US
Substituted pyridopyrimidinonyl compounds useful as t cell activators
US-2021061802-A1 · Mar 4, 2021 · US
Substituted naphthyridinone compounds useful as T cell activators
US-10669272-B2 · Jun 2, 2020 · US
Hepatitis C virus inhibitors
US-10617675-B2 · Apr 14, 2020 · US
Substituted naphthyridinone compounds useful as t cell activators
US-2020109140-A1 · Apr 9, 2020 · US
TGF-Beta Inhibitors
US-2020031832-A1 · Jan 30, 2020 · US
Tgf beta receptor antagonists
US-2019337942-A1 · Nov 7, 2019 · US
TGF Beta RECEPTOR ANTAGONISTS
US-2019292179-A1 · Sep 26, 2019 · US
TGFβ receptor antagonist
US-10336761-B2 · Jul 2, 2019 · US
TGF-β inhibitors
US-10287295-B2 · May 14, 2019 · US
Tgf beta receptor antagonists
US-2018250303-A1 · Sep 6, 2018 · US
Hepatitis c virus inhibitors
US-2018221342-A1 · Aug 9, 2018 · US
Tgf beta receptor antagonists
US-2018215761-A1 · Aug 2, 2018 · US
GDF-8 inhibitors
US-9981944-B2 · May 29, 2018 · US
TGF-Beta Inhibitors
US-2018127426-A1 · May 10, 2018 · US
TGF-beta inhibitors
US-9884868-B2 · Feb 6, 2018 · US
GDF-8 Inhibitors
US-2016264553-A1 · Sep 15, 2016 · US
TGF-Beta Inhibitors
US-2016257690-A1 · Sep 8, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 29 |
| Rigel Pharmaceuticals Inc | 9 |
| Bristol Meyers Squibb Co | 1 |
| Rigel Pharmaceuticals Hic | 1 |
| Juno Therapeutics Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 26 |
| C07D471/04 | 20 |
| C07D487/04 | 13 |
| A61P31/12 | 11 |
| A61P35/02 | 10 |